Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Deleporte, Amélie" or (type exact bookEditor and editor="Deleporte, Amélie")

Add to list
- Journal Article
- A1
- open access
Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer : a post hoc analysis of two non-randomized phase II trials

Nicolas Charette, Caroline Vandeputte, Lieveke Ameye, Camille Van Bogaert, Jonathan Krygier, Thomas Guiot, Amelie Deleporte, Thierry Delaunoit, Karen Geboes (UGent) , Jean-Luc Van Laethem, et al.

(2019) BMC CANCER. 19.
Add to list
- Conference Paper
- C3
Is a single driver gene mutation sufficient for monitoring early response in advanced colorectal cancer

Pashalina Kehagias, Caroline Vandeputte, Lieveke Ameye, Hakim El Housni, Amelie Deleporte, Karen Geboes (UGent) , Thierry Delaunoit, Gauthier Demolin, Marc Peeters, Lionel D'Hondt, et al.

(2019) CANCER RESEARCH. 79(13, suppl.).
Add to list
- Conference Paper
- C3
Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer : preliminary analysis of the PePiTA study

Alain Hendlisz, Rafael Caparica, Amelie Deleporte, Jean-Luc Van Laethem, Philippe Vergauwe, Marc Van den Eynde, Guido Deboever, Jozef Janssens, Gauthier Demolin, Stephane Holbrechts, et al.

(2019) JOURNAL OF CLINICAL ONCOLOGY. 37(15, suppl.).
Add to list
- Journal Article
- A2
- open access
Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor

Caroline Vandeputte, Pashalina Kehagias, Hakim El Housni, Lieveke Ameye, Jean-François Laes, Christine Desmedt, Christos Sotiriou, Amélie Deleporte, Francesco Puleo, Karen Geboes (UGent) , et al.

(2018) ONCOTARGET. 9(25). p.17756-17769
Add to list
- Conference Paper
- C3
Circulating tumor DNA detects early response to regorafenib in advanced colorectal cancer

Pashalina Kehagias, Caroline Vandeputte, Lieveke Ameye, Hakim El Housni, Jean-Francois Laes, Amelie Deleporte, Karen Geboes (UGent) , Thierry Delaunoit, Gauthier Demolin, Marc Peeters (UGent) , et al.

(2018) CANCER RESEARCH. In Cancer Research 78(13).
Add to list
- Conference Paper
- C3
High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib

Pashalina Kehagias, Caroline Vandeputte, Lieveke Ameye, Hakim El Housni, Amelie Deleporte, Karen Geboes (UGent) , Thierry Delaunoit, Marc Peeters (UGent) , Gauthier Demolin, Lionel D'Hondt, et al.

(2018) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 36(15).
Add to list
- Conference Paper
- C3
Regorafenib assessment guided by metabolic imaging in refractory advanced colorectal cancer (aCRC) : REGARD-C study

Alain Hendliz, Amélie Deleporte, Thierry Delaunois, Marc Peeters (UGent) , Gauthier Demolin, Jos Janssens, Stephane Holbrechts, Raphaël Maréchal, Javier Carasco, Marc Van Den Eynde, et al.

(2014) JOURNAL OF CLINICAL ONCOLOGY. 32(15, suppl.).
Add to list
- Journal Article
- A1
- open access
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study

Alain Hendlisz, Vassilis Golfinopoulos, Amelie Deleporte, Marianne Paesmans, Hazem El Mansy, Camilo Garcia, Marc Peeters, Lieven Annemans (UGent) , Caroline Vandeputte, Marion Maetens, et al.

(2013) BMC CANCER. 13.
Add to list
- Conference Paper
- C3
- open access
Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study

Ivan Borbath, Antonio Ceratti, Chris Verslype, Anne Demols, Thierry Delaunois, Stéphanie Laurent (UGent) , Amélie Deleporte, Philippe Vergauwe, Eric Van Cutsem and Jean-Luc Van Laethem

(2011) JOURNAL OF CLINICAL ONCOLOGY. 29(4, suppl.).

Academic Bibliography

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer : a post hoc analysis of two non-randomized phase II trials

Is a single driver gene mutation sufficient for monitoring early response in advanced colorectal cancer

Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer : preliminary analysis of the PePiTA study

Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor

Circulating tumor DNA detects early response to regorafenib in advanced colorectal cancer

High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib

Regorafenib assessment guided by metabolic imaging in refractory advanced colorectal cancer (aCRC) : REGARD-C study

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study

Contents

Support

Contact